Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.240
-0.090 (-6.77%)
At close: Jul 14, 2026, 4:00 PM EDT
1.250
+0.010 (0.81%)
After-hours: Jul 14, 2026, 6:32 PM EDT
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $160.34 million as of July 14, 2026. Its market cap has decreased by -10.09% in one year.
Market Cap
160.34M
Enterprise Value
164.55M
1-Year Change
-10.09%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $160.34M, an increase of 9.85%. That is a compound annual growth rate of 2.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 160.34M | -9.44% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 178.53M |
| Canton Strategic Holdings | 175.07M |
| Milestone Pharmaceuticals | 174.14M |
| NRx Pharmaceuticals | 173.93M |
| Innate Pharma | 171.59M |
| PepGen | 168.77M |
| Alector | 167.65M |
| Corbus Pharmaceuticals Holdings | 167.49M |